Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary A Ulaner

Showing results (121-130 of 152) with videos related to

Pageof 16
Sort By:
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|December 28, 2020
Diffusion and Perfusion MRI Predicts Response Preceding and Shortly After Radiosurgery to Brain Metastases: A Pilot StudyAkash Deelip Shah, Amaresha Shridhar Konar, Ramesh Paudyal, et al.
Journal of the American College of Radiology : JACR|December 1, 2023
ACR Appropriateness Criteria® Breast Implant Evaluation: 2023 Update, Alison Chetlen, Bethany L Niell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2021
CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 MinibodyMichael D Farwell, Raymond F Gamache, Hasan Babazada, et al.
Nature Communications|July 15, 2022
AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancerAditya Bardia, Sarat Chandarlapaty, Hannah M Linden, et al.
Journal of the American College of Radiology : JACR|November 27, 2022
ACR Appropriateness Criteria® Evaluation of Nipple Discharge: 2022 Update, Matthew F Sanford, Priscilla J Slanetz, et al.
Journal of the American College of Radiology : JACR|May 26, 2023
ACR Appropriateness Criteria® Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer: 2022 Update, Jessica H Hayward, Olivia E Linden, et al.
Journal of the American College of Radiology : JACR|November 27, 2022
ACR Appropriateness Criteria® Imaging After Breast Surgery, Tejas S Mehta, Ana P Lourenco, et al.
Breast (Edinburgh, Scotland)|September 20, 2024
Role of [<sup>18</sup>F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelinesDavid Groheux, Sofia C Vaz, Philip Poortmans, et al.
Cancers|November 6, 2020
The Contribution of MicroRNAs to the Inflammatory and Neoplastic Characteristics of Erdheim-Chester DiseaseRan Weissman, Eli L Diamond, Julien Haroche, et al.
JAMA Network Open|November 28, 2019
Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical TrialNeil M Iyengar, Lillian M Smyth, Diana Lake, et al.
Pageof 16

Showing results (121-130 of 152) with videos related to

Sort By:
Pageof 16
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|December 28, 2020
Diffusion and Perfusion MRI Predicts Response Preceding and Shortly After Radiosurgery to Brain Metastases: A Pilot StudyAkash Deelip Shah, Amaresha Shridhar Konar, Ramesh Paudyal, et al.
Journal of the American College of Radiology : JACR|December 1, 2023
ACR Appropriateness Criteria® Breast Implant Evaluation: 2023 Update, Alison Chetlen, Bethany L Niell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2021
CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 MinibodyMichael D Farwell, Raymond F Gamache, Hasan Babazada, et al.
Nature Communications|July 15, 2022
AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancerAditya Bardia, Sarat Chandarlapaty, Hannah M Linden, et al.
Journal of the American College of Radiology : JACR|November 27, 2022
ACR Appropriateness Criteria® Evaluation of Nipple Discharge: 2022 Update, Matthew F Sanford, Priscilla J Slanetz, et al.
Journal of the American College of Radiology : JACR|May 26, 2023
ACR Appropriateness Criteria® Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer: 2022 Update, Jessica H Hayward, Olivia E Linden, et al.
Journal of the American College of Radiology : JACR|November 27, 2022
ACR Appropriateness Criteria® Imaging After Breast Surgery, Tejas S Mehta, Ana P Lourenco, et al.
Breast (Edinburgh, Scotland)|September 20, 2024
Role of [<sup>18</sup>F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelinesDavid Groheux, Sofia C Vaz, Philip Poortmans, et al.
Cancers|November 6, 2020
The Contribution of MicroRNAs to the Inflammatory and Neoplastic Characteristics of Erdheim-Chester DiseaseRan Weissman, Eli L Diamond, Julien Haroche, et al.
JAMA Network Open|November 28, 2019
Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical TrialNeil M Iyengar, Lillian M Smyth, Diana Lake, et al.
Pageof 16